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Differential DNA methylation 
in recovery from shift work disorder
Alexandra Lahtinen1,2*, Antti Häkkinen3, Sampsa Puttonen4, Päivi Vanttola4, 
Katriina Viitasalo5, Tarja Porkka‑Heiskanen1, Mikko Härmä4 & Tiina Paunio1,2*
The human DNA methylome is responsive to our environment, but its dynamics remain 
underexplored. We investigated the temporal changes to DNA methylation (DNAme) in relation to 
recovery from a shift work disorder (SWD) by performing a paired epigenome‑wide analysis in an 
occupational cohort of 32 shift workers (25 men, age = 43.8 ± 8.8 years, 21 SWD cases). We found that 
the effect of vacation on DNAme was more prominent in the SWD‑group as compared to controls, 
with respect to the amount of significantly differentially methylated positions (DMPs; Punadj < 0.05) 
6.5 vs 3.7%, respectively. The vast majority (78%) of these DMPs were hypomethylated in SWD 
but not in controls (27%) during the work period. The Gene Ontology Cellular component “NMDA 
glutamate receptor” (PFDR < 0.05) was identified in a pathway analysis of the top 30 genes in SWD. 
In‑depth pathway analyses revealed that the Reactome pathway “CREB phosphorylation through 
the activation of CaMKII” might underlie the recovery. Furthermore, three DMPs from this pathway, 
corresponding to GRIN2C, CREB1, and CAMK2B, correlated with the degree of recovery (Punadj < 0.05). 
Our findings provide evidence for the dynamic nature of DNAme in relation to the recovery process 
from a circadian disorder, with biological relevance of the emerging pathways.
DNA methylation (DNAme) plays a crucial role during embryonic development. Accordingly, comparisons of 
various cell types showed that approximately 15–21% of genomic CpGs undergo dynamic changes in the con-
text of normal  development1,2. Once the DNAme pattern is established, it is maintained during cell divisions in 
order to retain cell  identity3. Outside of the early stages of development and within a non-pathological context, 
DNAme has been considered stable. Data emerging on aging has, however, indicated that DNAme is altered 
throughout the lifetime, resulting in site-specific hyper- or  hypomethylation3,4. Despite advances in studying 
DNAme in developmental contexts as well as across the human lifespan, we still have limited information on 
the short-term changes in DNAme patterns in humans.
Environmental influences constitute one of the most prominent causes in DNAme  changes5–7. A study of 
epigenetic differences in a cohort of monozygotic twins revealed that the patterns of DNAme and histone modi-
fications diverge with  aging8. Such differences in genetically identical individuals could be explained, to a large 
extent, by disparate lifestyles, e.g. diet, exercise habits, or smoking. Furthermore, these differences are likely to 
play an important role in the discordant frequency and onset of many diseases in monozygotic  twins9–11. All these 
studies point towards the intriguing hypothesis that DNAme is an important interface between the environment 
and the genome, and there is a need for specific studies focusing on exploring its dynamic nature. As most epig-
enome-wide association studies (EWAS) are cross-sectional, the dynamics of DNAme remain poorly explored.
Outside of oncology and studies focused on aging, longitudinal studies in humans are scarce and, to our 
best knowledge, there are no studies of DNAme on sleep disorders with longitudinal data. Earlier, we reported 
the results of a cross-sectional genome-wide analysis of DNAme in two cohorts—a community-based sample 
and an occupational cohort of shift  workers12. In general, sleep disorders, tiredness, and an increased risk of 
occupational injuries are associated with working in  shifts13,14. In the longer perspective, shift work is known to 
increase the risk for many adverse health effects, such as coronary heart disease (CHD)15–18, type 2  diabetes19–21, 
metabolic  syndrome19, breast  cancer22, and gastrointestinal disorders, such as peptic  ulcer23. As a common medi-
cal condition in shift workers, SWD is a circadian rhythm sleep–wake disorder characterized by symptoms of 
insomnia and/or excessive sleepiness associated with working  periods24. After a vacation period, these symptoms 
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ameliorate, and normal sleep–wake function should be restored. As many as one-third of shift workers develop 
 SWD25–27, thus making it a common condition that negatively affects work performance and disrupts family 
and social  life28–30. Importantly, the vulnerability to experience SWD symptoms varies remarkably between 
individuals: some shift workers tolerate and recover from shift work better than  others31–33, which is at least 
partially likely to result from genetic  influences34. Despite a growing interest to study the biology of tolerance 
and adaptation to shift work, little is known about the molecular processes that underlie recovery from shift 
work among those with SWD.
In order to explore the dynamic nature of DNAme and to investigate biological processes underlying recovery 
from SWD, we conducted enrichment analyses of the top findings of the methylation changes for the individu-
als suffering from SWD. We performed a paired epigenome-wide analysis of DNAme and, for the first time, 
evaluated the significance of a vacation-specific effect for each CpG in the Illumina 450 K array, separately for 
the SWD group and the controls. In post-hoc analyses, we assessed the association between the changes in 
DNAme and the degree of recovery and reported SWD-specific DNA methylation changes that may regulate 
the restoration of a healthy state.
Results
Methylome‑wide analyses of the paired Airline data. Our study focused on 32 shift workers (21 
cases with SWD, 11 controls, 7 women, age = 43.8 ± 8.8 years) with DNA samples collected during a working 
period and after a vacation. Based on the estimated change in recovery symptoms for each shift worker, we 
divided SWD individuals into three groups: well-recovered, recovered, and poorly recovered (See Table 2 in the 
Supplementary Methods for the characteristics of the SWD participants in the groups).
To estimate the effects of being on vacation, as opposed to working on DNAme, we performed EWAS employ-
ing a linear regression model (see “Methods” and Supplementary Methods). The effect of vacation was stronger 
in the SWD group as compared to controls. In SWD, 6.5% (28,419/433,479) of all CpGs were DMPs using an 
uncorrected P < 0.05 (469 CpGs with an FDR-corrected P < 0.3). In controls, 3.7% (16,056/433,479) of the CpGs 
were DMPs using an uncorrected P < 0.05 and none of the CpGs remained significant after the multiple testing 
correction procedure. The resulting quantile–quantile (QQ) plots for all models are shown in the Fig. 1. For 
Figure 1.  Quantile–quantile plots for (a) SWD group, (b) control group, (c) either group, and (d) both groups. 
Dots represents individual CpG sites and the line identity.
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the full list presenting the annotated 42,456 DMPs that were differentially methylated in SWD or controls, see 
Supplementary Data.
We identified a strong effect of vacation on the direction of methylation in the SWD group: 67% 
(290,430/433,479) of CpGs were hypomethylated during work as compared with vacation, constituting 78% 
(22,166/28,419) of the DMPs. The corresponding numbers for controls were 40% and 27%, respectively.
We next used the same linear regression model to estimate the effect of vacation in the three recovery groups 
of SWD individuals separately. Of the DMPs, only 397, 336, and 6,090 (less than 1.5%) were significant in the 
poorly recovered, recovered, and well-recovered SWD individuals, respectively. However, at 83% (331/397), 88% 
(299/336), and 79% (4,836/6,090) for the three groups, respectively, the DMPs were hypomethylated during work, 
as compared with vacation, similar to the overall trend of the SWD group.
Considering the prominent effect of vacation on methylation in the SWD group, we focused on these find-
ings in analysis of biological relevance: gene ontology and exploration of the vacation-sensitive pathways. For 
the subsequent analysis, we opted to pool the SWD individuals, due to a limited power to analyze sub-groups 
separately and due to increased hyper- vs hypomethylation as a result of vacation. We selected the top 30 genes 
(see Supplementary Table S1) ranked by significance (unadjusted P value < 1E-5, FDR-corrected P value ≤ 0.16) 
and subjected this set of genes to gene set enrichment analyses.
Gene ontology enrichment of the vacation‑sensitive gene set. Gene ontology analyses. To iden-
tify the affected biological pathways, we explored three gene set ontology (GO) libraries in  Enrichr35,36: GO 
Biological Process, GO Molecular Function, and GO Cellular Component 2018. The top finding from the GO 
Cellular Component 2018, “NMDA selective glutamate receptor complex” (GO:0017146), was found to be sta-
tistically significant at P < 0.05 even after correction for multiple testing (P = 8 × 10–5 , Benjamini-Hochberg (BH) 
-corrected P = 0.03). The top terms for GO Molecular Function 2018 and GO Biological processes 2018 were 
“NMDA glutamate receptor activity” (GO:0004972, P = 4 × 10–5, BH-corrected P = 0.05) and “Excitatory chemi-
cal synaptic transmission” (GO:0098976, P = 4 × 10–5, BH-corrected P = 0.23), respectively. The findings from 
GO enrichment analyses are summarized in Supplementary Table S2. Thus, the analyses revealed enrichment of 
biological processes related to the NMDA glutamate receptor complex in all three ontology libraries.
In‑depth analysis of the vacation‑sensitive pathways with reactome. We further explored the 
pathways involving the vacation-sensitive DMPs by using Reactome. The hierarchical structure of Reactome 
allows the dissection of the signals into detailed molecular  processes37. Analysis of the top 30 genes using Reac-
tome 2016 resulted in similar findings as those with GO, adding further evidence for the involvement of changes 
in glutamate transmission in relation to recovery from SWD (Supplementary Table S3 and Table 1). Further-
more, the results indicated that six out of the ten top findings (P value < 0.01) are hierarchically organized under 
the same parent term “Activation of NMDA receptor upon glutamate binding and postsynaptic events”. This 
Table 1.  Enrichment and hypomethylation scores for the significantly differentially methylated CpG sites 
(DMPs) in the top ten ranked Reactome 2016 pathways. a P value is unadjusted P value estimated by Enrichr 
from analysis of Top 30 genes. b Parent Pathway: “Activation of NMDA receptor upon glutamate binding and 
postsynaptic events_Homo sapiens_R-HSA-442755”. c Number of all 450 K Illumina CpGs corresponding to 
the genes enlisted for the pathway. d Number of genes enlisted for this pathway in Reactome 2016 library.
Rank REACTOME 2016 pathway P  valuea Included in the parent  pathwayb CpGs,  Nc Genes,  Nd
DMP enrichment 
score, %
DMP hypo score, 
%
Cases Controls Cases Controls
1 CREB phosphorylation through the activation of CaMKII_Homo sapiens_R-HSA-442729 2.2E-4 Yes 458 15 8.3 4.1 73.7 26.3
2 Ras activation upon Ca2 + infux through NMDA receptor_Homo sapiens_R-HSA-442982 2.9E-4 Yes 542 17 7.2 3.7 76.9 40.0
3 Unblocking of NMDA receptor. glutamate binding and activation_Homo sapiens_R-HSA-438066 2.9E-4 Yes 480 17 7.1 3.8 76.5 22.2
4 SALM protein interactions at the synapse_Homo sapiens_R-HSA-8849932 4.9E-4 No 592 20 5.6 3.0 75.8 22.2
5 CREB phosphorylation through the activation of Ras_Homo sapiens_R-HSA-442742 7.5E-4 Yes 913 27 7.6 3.2 79.7 34.5
6 Post NMDA receptor activation events_Homo sapiens_R-HSA-438064 1.2E-3 Yes 1078 35 7.5 3.4 80.2 35.1
7
Activation of NMDA receptor upon glutamate 
binding and postsynaptic events_Homo sapiens_R-
HSA-442755
1.6E-3 Yesb 1136 39 7.3 3.4 80.7 33.3
8 Signaling by Retinoic Acid_Homo sapiens_R-HSA-5362517 1.8E-3 No 727 39 5.6 3.3 78.0 33.3
9 Muscarinic acetylcholine receptors_Homo sapiens_R-HSA-390648 7.5E-3 No 100 5 4.0 2.0 100.0 100.0
10 Synthesis of Dolichyl-phosphate_Homo sapiens_R-HSA-446199 8.9E-6 No 73 6 5.5 2.7 100.0 50.0
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parent pathway is also included in the top-ranked pathway, “CREB phosphorylation through the activation of 
CaMKII” (Supplementary Fig. S1).
For the in-depth pathway analyses, we included CpGs corresponding to all genes listed in each of the Reac-
tome top 10 pathways (genes: n = 5–39 per pathway and CpGs: n = 73–1136 per gene, see Table 1). To investigate 
the DNAme changes from the paired EWAS study (work vs. vacation), we calculated the DMP enrichment and 
hypomethylation scores in the CpGs from each pathway both in the SWD and the control groups (Table 1). In 
the SWD group, we found the highest enrichment score (8.3%, 38/458) for the pathway “CREB phosphorylation 
through the activation of CaMKII” (CREB-CaMKII pathway). This pathway also showed hypomethylation in 74% 
of the DMPs (28/38) (for details, see Supplementary Table S4). In controls, the enrichment and hypomethylation 
scores for this pathway numbered 4.1% (19/458) and 26.3% (5/19), respectively. The QQ plots for CpGs from 
this pathway are displayed in Fig. 2a (SWD group) and 2b (controls), which show that the significant DMPs are 
frequent in cases but not in controls. Thus, our results provide evidence for a relatively robust involvement of 
CpGs from genes of the CREB-CaMKII pathway specific to the SWD group.
Figure 2.  Quantile–quantile plots for the epigenome-wide association in the 458 CpGs corresponding to 
15 genes from the pathway “CREB phosphorylation through the activation of CaMKII”: (a) SWD group, (b) 
controls. Dots represent individual CpG sites and the lines identity. (c) Volcano plot for the Reactome 2016 
pathway “CREB phosphorylation through the activation of CaMKII”. Colors of points correspond to: grey, CpGs 
with unadjusted P values > 0.05; green, DMPs for SWD group; black, DMPs for the controls.
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In order to visualize the magnitude, direction, and significance of the DNAme changes induced by vacation for 
this pathway, we utilized a scatter plot (‘volcano plot’) visualization (Fig. 2c). The largest changes in hypermeth-
ylation, along with the highest statistical significance in SWD group were observed for the DMPs corresponding 
to the genes encoding NMDA receptor subunits GRIN2C and GRIN2D. We also discovered DMPs correspond-
ing to 13/15 genes (GRIN2A, GRIN2B, GRIN2C, GRIN2D, CAMK2A, CAMK2B, CAMK2D, CAMK2G, CREB1, 
CALM1, DLG4, ACTN2, AKAP9) in this pathway in the SWD group, suggesting that virtually all genes in this 
pathway had one or more CpGs affected by the vacation.
In‑depth analysis of DMPs from the CREB‑CamKII pathway. Correlations of vacation M‑values with 
the recovery in SWD group. We further investigated whether the changes in the methylation values (M-values) 
of the 38 DMPs from the CREB-CaMKII pathway correlate with the degree of recovery in the SWD group based 
on data from on-site questionnaires. We found 3/38 DMPs to correlate at P < 0.05 with the degree of recovery, 
none of which remained significant after multiple testing correction (Table 2 and Supplementary Table S5). The 
change in M-values correlated inversely with the degree of recovery for cg13823003 (GRIN2C), cg05019488 
(CREB1), and cg18848222 (CAMK2B), as all three sites showed hypomethylation during working period as 
compared with vacation. Figure 3 illustrates the biggest absolute change in the M-values of individuals with the 
highest degree of recovery.
SWD vs. controls during work. We then compared the methylation levels of the 38 DMPs in the SWD group 
and the controls during the working period. In the SWD group, 28/38 of the sites were hypomethylated and, 
respectively, 10/38 were hypermethylated, during the working period, as compared with vacation. The majority 
of the hypomethylated (20/28) sites showed lower M-values in the SWD group as compared with the controls; 
accordingly, the majority (9/10) of the hypermethylated showed higher M-values in SWD (one site, cg13823003 
from GRIN2C, with a nominally significant difference at P < 0.05, analysis of variance (ANOVA) (Supplementary 
Table S6).
The results of the in-depth analysis of the CREB-CaMKII pathway are summarized in the Table 3. Of all 
the DMPs identified, the findings with cg13823003, corresponding to gene GRIN2C, were the most robust and 
exhibited all the following properties: a nominally significant P value < 0.05 in the secondary analyses of recovery; 
ANOVA analysis indicated an altered behavior during the working period; and the site was among the 30 most 
significant sites for the pathway analysis.
Global DNAme patterns across the recovery groups of SWD group. In order to explore global 
DNAme patterns across the recovery groups of SWD individuals and to compare them with DNAme patterns of 
Table 2.  Correlation between the methylation changes with the changes in recovery symptoms: the three 
identified DMPs and the corresponding genes. a P value, uncorrected P value, 2-tailed; q value, FDR-corrected 
P value.
DMP Gene Chromosome Coordinate Spearman correlation, r P value q value
cg13823003 GRIN2C 17 70367644 − 0.622 0.003 0.205
cg05019488 CREB1 2 208173979 − 0.493 0.023 0.488
cg18848222 CAMK2B 7 44225262 − 0.485 0.026 0.488
Figure 3.  Boxplots of the three discovered differentially methylated CpG in the Reactome 2016 pathway “CREB 
phosphorylation through the activation of CaMKII” for the groups with different degree of recovery. Y-axis 
represents the absolute change in the M-values from work to vacation. Colors of the dots correspond to the 
different groups: red, poorly recovered; blue, recovered; green, well-recovered. The horizontal line is median, 
box is 25 to 75%, the whiskers denote data, and the dots represent individual samples.
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controls, we performed a t-SNE mapping of the global DNA methylome profiles (Fig. 4). Globally the methyla-
tion profiles of the well-recovered individuals resembled the profiles of the controls, while the poorly recovered 
and recovered individuals cluster separately at specific regions of the DNA methylome space.
Discussion
In order to gain insight into the dynamic nature of DNAme, we explored the effect of vacation on DNAme com-
pared to a working period in shift workers. Our hypothesis was that among the shift workers with SWD, recovery 
from insufficient sleep would be reflected in the changes of DNAme patterns in white blood cells. This study 
used paired data from an occupational cohort of shift workers, with and without SWD, for genome-wide analysis 
of DNAme from whole blood samples, in combination with information from sleep diaries and questionnaires 
collected during work and after vacation. To the best of our knowledge, this is the first study to longitudinally 
examine dynamic DNAme changes in relation to a manifesting sleep disorder and recovery from it.
The main finding of this study is that the effect of vacation on DNAme was more prominent in the SWD 
group, as compared to the controls, with dynamic changes observed in 6.5% of the DMPs. The observed changes 
included a gain in methylation induced by vacation, which was more remarkable for the individuals suffering 
Table 3.  Summary of the results of each analysis for the 38 DMPs from the pathway “CREB phosphorylation 
through the activation of CaMKII”.
Gene DMP
EWAS cases
ANOVA at work P value
Secondary analyses of 
recovery
Sign at work P value Spearman r P value
ACTN2 cg11197458 Hypo 0.020 0.677 − 0.270 0.237
ACTN2 cg12297935 Hypo 0.014 0.408 − 0.181 0.432
ACTN2 cg23109559 Hypo 0.011 0.499 0.265 0.246
ACTN2 cg23233975 Hypo 0.019 0.355 − 0.133 0.566
ACTN2 cg26406150 Hypo 0.019 0.914 0.050 0.831
AKAP9 cg16688376 Hypo 0.046 0.822 − 0.083 0.720
CALM1 cg01311654 Hyper 0.042 0.355 0.334 0.138
CALM1 cg04712435 Hypo 0.003 0.834 0.345 0.125
CALM1 cg05077358 Hypo 0.004 0.650 0.408 0.066
CAMK2A cg03873049 Hypo 0.004 0.592 0.015 0.949
CAMK2A cg06620397 Hypo 0.015 0.233 − 0.318 0.160
CAMK2B cg18848222 Hypo 0.017 0.602 − 0.485 0.026
CAMK2B cg23997477 Hypo 0.008 0.132 0.149 0.519
CAMK2D cg13801347 Hypo 0.010 0.915 0.008 0.972
CAMK2D cg17237111 Hyper 6.399E−05 0.236 0.024 0.917
CAMK2D cg20391984 Hyper 0.005 0.379 0.077 0.742
CAMK2G cg02032166 Hypo 0.049 0.921 − 0.169 0.463
CAMK2G cg08797625 Hyper 0.010 0.939 − 0.087 0.707
CAMK2G cg17422824 Hypo 0.021 0.499 0.102 0.660
CREB1 cg05019488 Hypo 0.006 0.765 − 0.493 0.023
CREB1 cg14129040 Hypo 0.031 0.290 − 0.197 0.391
CREB1 cg15749141 Hyper 0.006 0.342 0.353 0.116
DLG4 cg13729891 Hyper 0.034 0.170 − 0.179 0.439
DLG4 cg21218476 Hyper 0.011 0.482 − 0.114 0.622
GRIN2A cg00534626 Hypo 0.001 0.099 − 0.032 0.890
GRIN2A cg01344243 Hypo 0.044 0.204 0.068 0.768
GRIN2A cg06829391 Hypo 0.009 0.414 0.136 0.558
GRIN2A cg09461286 Hypo 0.028 0.219 0.191 0.408
GRIN2A cg16378117 Hypo 0.032 0.942 0.257 0.262
GRIN2B cg03777288 Hypo 0.042 0.073 − 0.085 0.715
GRIN2B cg14351692 Hypo 0.007 0.694 0.185 0.421
GRIN2B cg23942984 Hypo 0.018 0.162 − 0.083 0.720
GRIN2C cg09722397 Hyper 0.006 0.363 0.068 0.768
GRIN2C cg13823003 Hypo 3.076E−06 0.037 − 0.622 0.003
GRIN2C cg18035537 Hyper 0.040 0.147 − 0.188 0.414
GRIN2C cg21997766 Hyper 0.039 0.248 0.121 0.602
GRIN2D cg08525508 Hypo 0.034 0.078 0.269 0.239
GRIN2D cg12546181 Hypo 1.217E−05 0.086 0.106 0.647
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from SWD, as compared with the controls. An overall trend towards global DNAme hypomethylation was earlier 
reported in several epigenome-wide association studies conducted in the cohorts of shift  workers38–40. Moreover, 
this finding is in accordance with our previous  study12, where we observed a loss of methylation in individuals 
suffering from insufficient sleep. In the current study, we further confirmed that insufficient sleep during work 
is associated with hypomethylation, while the recovery from SWD symptoms during vacation corresponded to 
the restoration of methylation.
Gene enrichment analyses of the DMPs which showed the largest changes after vacation in the SWD group 
revealed pathways related to the activity of a glutamatergic NMDA receptor. These pathways included GRIN-
subunits of NMDA receptor, several  Ca2+/calmodulin-dependent protein kinases (CaM kinases), and the tran-
scription factor CREB1. This study’s focus on longitudinal observations of the shift workers enabled us to narrow 
down a wide group of pathways to the specific molecular process involving only a few genes. In depth analysis 
revealed the Reactome pathway “CREB phosphorylation through the activation of CaMKII” to have the highest 
enrichment of methylome changes. This pathway includes the genes encoding for cAMP responsive element 
binding protein 1 (CREB1), calcium/calmodulin dependent protein kinase II beta (CAMK2B), and glutamate 
ionotropic receptor NMDA type, subunit 2C (GRIN2C).
Recovery dynamics in shift workers in the SWD group were found to be highly individual, with some shift 
workers reporting full recovery, while others still mentioned sleepiness and insomnia even after the vacation. We 
found that the largest changes in recovery symptoms were accompanied by the largest DNAme changes of three 
CpGs from the CREB-CaMKII pathway. One of them, a CpG site cg13823003 from GRIN2C, was remarkably 
robust through our study, showing statistical significance both in ANOVA analysis during the working period 
and in the secondary analyses of recovery. This site was also among the top DMPs obtained from the paired 
EWAS. According to the Ensembl Regulatory Build in Ensembl (http://www.ensem bl.org/info/genom e/funcg 
en/index .html) and Illumina 450 K annotation, cg13823003 locates at the CpG Island in the GRIN2C promoter 
and CTCF-binding site. In the same CpG Island in the TSS200 region, we found two adjacent CpG sites, which 
were differentially hypermethylated during work in SWD cases (See Supplementary Table S7 for details). Inter-
estingly, one of these sites, cg09722397, was identified earlier in our previous study in a sample of adolescents 
suffering from depression and comorbid  insomnia41. In coherence with the present study, where this site was 
hypermethylated in SWD cases during work, it was hypermethylated also among the adolescent cases, as com-
pared to age and gender-matched healthy controls. However, the opposite direction of methylation observed in 
these three CpGs located at the promoter of GRIN2C (two hyper- and one hypomethylated) presents a challenge 
for an attempt to propose the possible consequences for gene expression.
The members of the CREB-CAMK pathway that we identified in the present study belong to the 
 Ca2+-dependent hyperpolarization pathway, which has been implicated in the regulation of sleep  duration42. 
Several other studies exploring knockouts of the genes activating the  Ca2+-dependent hyperpolarization path-
way resulted in the same conclusion: the activity of these genes is associated with the cortical capacity to evoke 
slow-wave oscillations, which, in turn, is proportional to animal sleep  duration43–45.
As our study was carried out in the DNA samples from peripheral blood, we explored what is known about 
possible functions of such key members of CREB-CAMK pathway, as GRIN-subunits of NMDA receptor, CaM 
kinases, and CREB1 in the white blood cells.
Figure 4.  T-SNE mapping of the global DNA methylome profiles across the recovery groups of SWD group. 
Colors of the dots correspond to the different groups: red, poorly recovered; blue, recovered; green, well-
recovered; grey, controls. Hollow markers represent samples collected during work and filled ones during 
vacation, dashed lines connecting the samples of each patient.
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Human lymphocytes express various receptors, including NMDA glutamate receptors. The activation of these 
receptors may be involved in lymphocyte survival and differentiation of T-cells, and modulations of immune 
functions, as suggested by studies using NMDA receptor- binding, structural glutamate  analogues46.
CRE elements have been identified in the promoters of many T-cell genes, indicating that transcription factor 
CREB might be involved in processes, such as activation and proliferation of T and B cells, as well as monocyte 
 survival47. Less is known about calcium-calmodulin pathway, though some rodent studies evidenced involvement 
of CaM  kinases48 and calmodulin in the cytokine production, T cell activation and  proliferation49. Based on our 
findings from the white blood cells, it is possible to suggest that the vacation-induced changes in the activity of 
some members of CREB-CAMK pathway might be regulated via DNA methylation. The observed alterations in 
DNAme of GRIN-subunits, CREB, and CaM kinases may indicate immune function-related differences between 
individuals with SWD and controls. Several previous studies have shown an association between continuous sleep 
insufficiency, common among the shift workers, and alterations in host defence and  immunity50–55.
Our analysis of the global DNAme profiles in the recovery groups of individuals with SWD showed no clear 
differences in the degree of changes in poor versus well-recovered groups. This supports our findings from 
epigenome-wide association study and gene enrichment analyses, suggesting that the vacation did not affect 
DNAme in a genome-wide fashion, but affected the CpGs locally in specific pathways.
There are several limitations in this study. Firstly, the sample size was limited, and larger samples are required 
to detect statistically robust findings on a larger scale. However, a carefully a priori selected study design with 
two data collection points allowed us to detect statistically significant differences by applying a statistical model 
and assessing differences separately for the groups. Furthermore, the SWD and non-SWD status was assessed by 
both objective and subjective measurements, as in addition to the questionnaires, we performed both actigraphy 
monitoring and evaluated sleep diaries, as required by the International Classification of Sleep disorders-Third 
Edition (ICSD-3)  criteria56. The second limitation is that in the EWAS study of the whole blood samples we did 
not perform adjustment for the blood cell type composition. However, prior to analyses, we estimated that our 
groups did not differ in their blood cell type composition, nor did this composition change from working period 
to vacation in the same individual. Thus, most of the significant changes in DNAme observed after the vacation 
are unlikely to be explained by the cell type composition. Thirdly, we lacked objective measurements of sleep 
insufficiency and relied on self-reported data in the post-hoc analyses. Nevertheless, it is known that there are 
large individual differences in shift work  tolerance31–33 and self-reported data allowed us to capture such vari-
ability among the shift workers and identify specific sites that are sensitive for the degree of recovery. We also 
lacked the information regarding the chronotype and sleep/wake habits of our subjects. The fourth limitation 
relates to the statistically significant differences in age observed between SWD cases and controls. Since age has 
a known impact on the DNAme, we included age as a covariate in our model. The fifth limitation of our study 
was that we could not assess the functional significance of the identified DNAme changes due to absence of cor-
responding gene expression data. The last potential limitation is related to the possible order effect of this study: 
we investigated the changes occurring from the SWD-symptoms towards the recovery, but the changes from 
recovered to the diseased state could be asymmetric.
Despite these weaknesses, our study is one of the few existing paired EWASes investigating short-term changes 
in DNAme patterns in humans. We observed prominent methylation changes within several months in the 
SWD group and depicted a molecular brain-specific pathway associated with these changes. Furthermore, we 
distinguished specific molecules that might indicate the degree of recovery of a shift worker with SWD. Further 
studies in larger cohorts are required to fully uncover the mechanisms and validate their health-related potential.
Conclusion
Our findings suggest that the DNAme of shift workers shows a specific response to vacation, particularly in indi-
viduals suffering from SWD symptoms. The observed differences in methylation patterns take place in processes 
related to NMDA receptor activity. In particular, our analysis identified the CpG sites in GRIN2C, CREB1, and 
CAMK2B as putatively important indicators of recovery in a shift worker with SWD symptoms. Further, our 
results demonstrate that even a two-week period of vacation exerts changes in the human DNA methylome – a 
highly dynamic and complex regulatory mechanism that we are only beginning to understand.
Methods
Study design and participants. Paired measurements. Whole blood samples, sleep diaries, and ques-
tionnaires on SWD symptoms were collected twice in the lab for each participant. The ‘working period’ meas-
urement was performed during the shift worker’s working period: blood samples were collected between 7 a.m. 
and 11 a.m. from a healthy participant, with no infection episode in the previous 7 days. On the same morning, 
the participant completed the questionnaire in the lab. ‘Work’ sample collection dates varied between May 2012 
and June of 2013. The ‘vacation’ measurement was performed after at least two weeks of vacation (at the last day 
of vacation). The blood sample was collected between 7 a.m. and 11 a.m., and each participant completed the 
questionnaire. ‘Vacation’ sample collection dates varied between June 2012 and August 2013.
Participants. 32 shift workers aged 27–60 years (22% women) from a Finnish airline company were  involved31. 
The work schedule during the last 12 months included regular night shifts (a minimum of 3 h of work between 
11 p.m. and 6 a.m.) and/or early morning shifts (starting by 6 a.m.).
SWD status. The SWD and non-SWD (control) status was assessed by both subjective and objective measure-
ments: (1) shift working day -specific insomnia and sleepiness symptoms reported in the questionnaire, and (2) a 
working shift-related reduction of the total sleep time reported in the sleep diaries and actigraphy monitoring, as 
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required by the International Classification of Sleep disorders-Third Edition (ICSD-3)  criteria56. 21 shift workers 
(24% women, age = 41.0 ± 8.9 years) constituted the SWD group: a participant reported symptoms of insomnia 
and/or sleepiness “often/continuously” during working period only and had a reduced total sleep time. 11 shift 
workers (18% women, age = 49.2 ± 9.1 years) lacking the symptoms were deemed as controls. The SWD status 
assessment is described in detail in our previous  studies12,31.
Recovery groups in the SWD group. To assess the degree of recovery in the SWD group, we used two questions 
from the on-site questionnaire that measured important aspects of recovery for shift workers: (A) “How often 
do you not feel fresh after sleep?” and (B) “How often do you feel daytime sleepiness?”. The change in recovery 
symptoms for each shift worker in the SWD group was estimated from the difference as follows:
Tables 1 and 2 in Supplementary Methods summarize the participants’ characteristics.
Infinium human methylation 450K bead chip methylation measurements. The DNA extraction, 
CpG methylation, and quality control procedures are described in detail in Lahtinen et al.12. DNA was extracted 
from the whole blood samples using standard methods (See Supplementary Methods for details) and meth-
ylation measurements were performed using Infinium HumanMethylation450k BeadChip (Illumina, Inc., San 
Diego, CA, USA). Methylation data preprocessing and quality control were performed using R package “minfi” 
v1.18.457 in R software v3.6.1 (https ://www.r-proje ct.org/). 433,479 probes passed the quality control.
Data analyses. Methylome‑wide paired analysis. To estimate an effect of being on vacation as opposed 
to working on the methylation of each of the n probes in the m individuals, we employed the following linear 
regression model:
where y i, 0, j and y i, 1, j are the methylation of the i:th individual at the j:th probe when on work and vacation, 
respectively; h i is a flag indicating if the individual belongs to the SWD group or control (hi = 1 for a control 
and hi = 0 for the SWD group); vi is a flag indicating if the measurement is from a vacation period or not (vi = 0 
for the working period, vi = 1 for vacation); Dj are the nuisances such as age, sex, plate, alcohol consumption, 
and smoking status; and εi,1,j are the errors, assumed to be independent and identically distributed zero-mean 
normal random variables (i.e. the effects were found using the ordinary least squares procedure). In this model, 
β h=0, j and β h=1, j represent the group average methylation for the SWD and control groups (at the j:th probe) 
when working, respectively (after removing the nuisance effects); β v-w, h=0, j and β v-w, h=1, j represent the effect of 
vacation (versus work) on the methylation in the two groups; and β D, j the nuisance effects.
The significance of the effect of vacation (versus work) on the methylation of the j:th probe, β v-w, h, j, was tested 
using a variance ratio (F) test. The relevant null hypotheses considered no effect on each, either, or both groups, 
that is, the null hypothesis β v-w, h=0, j = 0 and β v-w, h=1, j = 0 tested for an effect on either group; β v-w, h=0, j = 0 tested 
for an effect in the SWD group, while β v-w, h=1, j = 0 tested for an effect in the control group; and the hypothesis 
β v-w, h=0, j = 0 or β v-w, h=1, j = 0 (which can be evaluated using a composite null model) tested for an effect in both 
groups. Finally, the acquired P values were adjusted to control false discovery rate (FDR) in multiple hypothesis 
testing using the Benjamini–Hochberg procedure. We defined a CpG site to be hyper- or hypomethylated based 
on the value of the beta coefficient in our tests, with hypermethylation characterized by a positive value. To esti-
mate the relative proportions of cell type components in the whole blood we used a statistical method described 
by Houseman et al.58. T-test was used to investigate the differences in the cell type compositions between and 
within the groups.
In order to obtain the gene names associated with the CpGs, we used Infinium HumanMethylation450k Bead-
Chip annotation data (Illumina, Inc., San Diego, CA, USA) and R software v3.6.1 (https ://www.r-proje ct.org/).
Pathway analyses using Enrichr. Enriched terms were explored using Enrichr (https ://amp.pharm .mssm.edu/
Enric hr/)36. We focused on three GO libraries: GO Biological Process, GO Molecular Function, and GO Cellular 
Component 2018. A list of genes ranked by P values served as the input and P < 0.05 (after Benjamini–Hochberg 
correction) was used to determine significance.
In‑depth pathway analysis using Reactome 2016. For the top 10 Reactome 2016 pathways ranked by unadjusted 
P values, we extracted the full gene set from Reactome 2016 library and calculated the (1) enrichment score (%) 
and (2) hypomethylation score (%), for both the SWD and control groups.
Post‑hoc analyses of the changes in M‑values in the recovery groups. To estimate the change in the methylation 
values in the SWD group, we calculated the difference between the M-values measured during the working 
period and vacation, as follows:
CHANGE_SYMPTOMS = (A + B)WORK −− (A + B)VACATION
yi, v{i}, j = (1− hi)βh=0,j + hiβh=1,j + (1− hi)viβv−w,h=0,j + hiviβv−w,h=1,j + Di,jβD,j + εi,v{i},j
for i in {1, . . . ,m}, viin {0, 1}, j in {1, . . . , n}
CHANGE_METHYLATION = M − VALUEWORK −−M − VALUEVACATION
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The Spearman correlation between the M-value changes and the recovery symptom changes (CHANGE_
SYMPTOMS, as defined earlier) was used to estimate recovery association. A P value < 0.05 (after Benja-
mini–Hochberg correction) was used to determine significance.
Post‑hoc analyses during working period. ANOVA was performed for the methylation measured during the 
working period. A P value < 0.05 (after Benjamini–Hochberg correction) was used to determine significance.
Assessment of global DNAme profiles in the recovery groups.  T-SNE mapping of the global methylome profiles 
was performed using software Rtsne 0.1559. Perplexity was set to 10 (cf. 64 samples), and 10,000 iterations were 
run.
Study approval. Sample collection and study design were performed according to the principles of the 
Declaration of Helsinki and were approved by Coordinating Ethics Committee of the Helsinki and Uusimaa 
Hospital District. All participants provided written informed consent.
Data availability
The ethical approval limits the individual-level data availability from the Airline cohort and prohibits the authors 
from making the data set publicly available. Data are available from the corresponding author (Tiina Paunio) 
upon ethical approval from the Coordinating Ethics Committee of the Helsinki and Uusimaa Hospital District.
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